AI tackles the scientist shortage to find cures for rare diseases
AI is becoming a superhuman lab partner to fight diseases the industry has ignored.
Deep Dive
Biotech executives say a critical shortage of scientists has left thousands of rare diseases untreated. AI is now acting as a 'force multiplier,' automating complex drug discovery tasks to identify new treatments and repurpose old drugs faster and cheaper. For example, Insilico Medicine's AI platform recently screened for ALS treatments. The goal is to build 'pharmaceutical superintelligence' that can work with unprecedented speed and accuracy where human labor is scarce.
Why It Matters
This could dramatically accelerate cures for millions of patients with neglected conditions.